Skip to content
Home/Companies/Biotech/Angarus Therapeutics
Angarus Therapeutics

Angarus Therapeutics

Biotech·Spain·Active·4yr hold
Entry
2022
Hold
4yr
Status
Active

Who owns Angarus Therapeutics?

Angarus Therapeutics is currently owned by Nara Capital Partners through Nara Health Capital (2022 vintage), since 2022.

Hand-verified · updated 2026-08-03

Nara Capital Partners
Investor
Nara Capital Partners
Nara Health Capital · 2022 · Life Sciences VC

Key facts

HQSpain
SectorBiotech
StatusActive
Websiteangarustx.com

More from Nara Health Capital

Other portfolio companies in the same fund.

Aortyx
Active
MedTechSpain· 2025
Gyala Therapeutics
Gyala Therapeutics
Active
BiotechSpain· 2025
Affirma Bio
Affirma Bio
Active
BiotechSpain· 2024
BioIntaxis
Active
BiotechSpain· 2024
HEECAP
Heecap
Active
MedTechSpain· 2024
Innitius
Innitius
Active
MedTechSpain· 2023

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Antiverse
Antiverse
Active
Future Planet CapitalUK
CellCentric
CellCentric
Active
Future Planet CapitalUK
Crescendo Biologics
Crescendo Biologics
Active
Future Planet CapitalUK
Cytox Group
Exited 2024
Future Planet CapitalUK
GenSight Biologics
GenSight Biologics
Active
Sofinnova PartnersFrance
Healx
Healx
Active
Amadeus Capital PartnersUK
Track Angarus Therapeutics

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Angarus Therapeutics.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue